Organogenesis Holdings Inc.

ORGO · NasdaqCM

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analyst

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders47.5%

Institutions51.8%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$564.17M	$482.04M	$450.89M	$468.06M	$338.30M	$260.98M	$193.45M	–	–
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	–	$115.74M	$105.02M	$114.20M	$87.32M	$75.95M	$68.81M	–	–
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	–	$366.30M	$345.87M	$353.86M	$250.98M	$185.03M	$124.64M	–	–
Gross profit as a percentage of revenue.	–	76.0%	76.7%	75.6%	74.2%	70.9%	64.4%	–	–
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$44.69M	-$1.28M	$22.30M	$72.92M	$27.41M	-$29.46M	-$51.56M	-$4.59M	–
Operating income as a percentage of revenue.	7.9%	-0.3%	4.9%	15.6%	8.1%	-11.3%	-26.7%	–	–
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$37.03M	$861000	$15.53M	$94.90M	$17.95M	-$40.45M	-$64.83M	-$2.09M	-$208698
Net income divided by the number of shares outstanding — profit attributable to each share.	$0.16	$-0.01	$0.12	$0.74	$0.17	$0.00	$0.00	$0.00	$0.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$0.15	$-0.01	$0.12	$0.71	$0.16	–	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$93.68M	$135.57M	$102.48M	$113.93M	–	–	–	–	–
Everything the company owns that has value — cash, property, inventory, investments, and more.	$598.73M	$497.89M	$449.36M	$443.26M	$294.49M	$220.69M	$163.68M	$312.79M	$311.44M
All of the company's interest-bearing borrowings, short and long term combined.	–	–	$4.54M	$2.66M	$16.67M	$49.63M	$2.54M	–	–
Everything the company owes — debt, unpaid bills, and other obligations.	$164.81M	$112.57M	$183.69M	$201.22M	$148.41M	$165.10M	$116.64M	$14.78M	$11.33M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$300.13M	$262.90M	$265.67M	$242.03M	$146.08M	$55.58M	$47.04M	$5.00M	$5.00M

Cash Flow Statement

	2025-12-31	2024-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$10.31M	$14.21M	$24.86M	$61.98M	$6.80M	-$33.53M	-$60.74M	-$586604	-$562233
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$14.15M	$10.03M	$33.90M	$31.22M	$21.14M	$5.98M	$1.86M	–	–
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$24.46M	$4.18M	-$9.04M	$30.76M	-$14.34M	-$39.51M	-$62.60M	–	–

	You	Peer avg
Revenue Growth	-56.7%	+577.9%
ROE	-25.9%	-66.3%

Organogenesis Holdings Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison